SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

HC Wainwright & Co. Reiterates Buy on Co-Diagnostics, Raises Price Target to $35

HC Wainwright & Co. reiterates Co-Diagnostics (NASDAQ:CODX) with a Buy and raises the price target from $20 to $35.

Benzinga · 05/18/2020 11:31

HC Wainwright & Co. reiterates Co-Diagnostics (NASDAQ:CODX) with a Buy and raises the price target from $20 to $35.